<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Nagahama_Intgrated_Human_Practice skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Nagahama/Intgrated Human Practice</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="menu_wrapper"><DIV class="collapsable_menu_control"> MENU ▤ </DIV><UL id="accordion" class="accordion"><LI class="menu_item"><A href="https://2016.igem.org/Team:Nagahama">HOME </A></LI><LI class="menu_item"> PROJECT  
			</LI><LI><A href="https://2016.igem.org/Team:Nagahama/Introduction">   ・Introduction </A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/Result and Discussion"> ・Result and Discussion </A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/Future"> ・Future </A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/Protocol"> ・Protocol </A></LI></UL><LI class="menu_item"> BioBricks  
			</LI><LI><A href="https://2016.igem.org/Team:Nagahama/Our all BioBricks">  ・Our all BioBricks </A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/BioBricks for medal"> ・BioBricks for medal </A></LI><LI class="menu_item"><A href="https://2016.igem.org/Team:Nagahama/Safety"> Safety </A></LI><LI class="menu_item"> Attributions
			</LI><LI><A href="https://2016.igem.org/Team:Nagahama/Team">  ・Team</A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/Attributions"> ・Attributions </A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/Sponsors"> ・Sponsors</A></LI><LI class="menu_item"> Collaborations
			</LI><LI><A href="https://2016.igem.org/Team:Nagahama/Collaborations">  ・Collaborations</A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/The Annual Meeting Of The Genetics Society Of Japan"> ・The Annual Meeting Of The Genetics Society Of Japan </A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/Support Gifu"> ・Support Gifu</A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/virginia">  ・Virginia</A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/Paris-Saclay">  ・Paris-Saclay</A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/Munich United"> ・Munich United</A></LI><LI class="menu_item"> Human Practice
			</LI><LI><A href="https://2016.igem.org/Team:Nagahama/Human Practice"> ・Human Practice </A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/Contacting Local"> ・Contacting Local</A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/Contacting Japan"> ・Contacting Japan</A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/Intgrated Human Practice"> ・Intgrated Human Practice</A></LI><LI class="menu_item"><A href="https://2016.igem.org/Team:Nagahama/Proof of concept"> Proof of concept </A></LI><LI class="menu_item"><A href="https://2016.igem.org/Team:Nagahama/Demonstrate your work"> Demonstrate your work </A></LI></DIV><DIV class="content_wrapper"><P>We explained our project and synthetic biology to the local people.Furthermore, in order to make our project and synthetic biology known nationwide, we used website, television programs, newspapers and radio.As a result, we received some useful feedbacks from the general public.Two of the feedbacks raised very important issued.
<STRONG>First issue &quot;Fragrance on food&quot;</STRONG>When food is kept an ‘Flavorator’, the fragrance might adhere to the food that you want to preserve.<STRONG>Second issue &quot;Recombinant, may go out of the laboratory. ⇒Recombinant releases&quot;</STRONG>Each solution of these problems to be integrated with the project.</P><H5><SPAN class="mw-headline" id="About_the_first_issue">About the first issue</SPAN></H5><P>We decided to use farnesol from the scent ingredient, with antibacterial properties, because it is almost odorless.This was the target, and solve the first Issue.</P><H5><SPAN class="mw-headline" id="About_the_second_issue">About the second issue</SPAN></H5><P>A method in which antimicrobial volatile gaseous substances synthesized using only the endogenous gene of <EM>E. coli</EM>.Specifically, we used the CRISPR-Cas9.Gene of extra in pathway to synthesis of farnesol, unnecessary intermediate metabolite (non-essential) synthase gene, knocked out.Gene involved in farnesol synthesized by those of endogenous <EM>E. coli</EM> knock in.Two issues are solved by these solutions.Integrated was completed.</P></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>